Strides Pharma recalls over 6 lakh bottles of blood pressure treatment tablets in US
As per the latest enforcement report by USFDA, the company, which is a unit of Bengaluru-headquartered Strides Pharma Science, is recalling 6,78,829 bottles of the blood pressure lowering drug in the US market.
Strides Pharma receives FDA approval for Ibuprofen suspension
US market for the suspension is pegged at around $41 million and this product will be manufactured at the company's facility at Bengaluru.
Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Strides receives USFDA approval for Ibuprofen OTC Oral Suspension Strides Pharma Science Ltd - 532531 - Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
With reference to above, please find enclosed the disclosure of Related Party Transactions, on consolidated basis, for the half year ended March 31, 2022 in the format specified under SEBI Circular bearing reference no. SEBI/HO/CFD/CMD1/CIR/P/2021/662 dated November 22, 2021. This is for your information and records. Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement of the Notice of Postal Ballot Strides Pharma Science Ltd - 532531 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Strides - Notice of Postal Ballot dated May 24, 2022 Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Transcript of Earnings call Strides Pharma gets USFDA approval for generic Ibuprofen oral suspension
The product will be manufactured at the firm's facility in Bengaluru and will be marketed by Strides Pharma Inc in the US market Strides Pharma Science Ltd - 532531 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for the year ended March 31, 2022 Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Strides receives USFDA approval for Ibuprofen Oral Suspension